Optical control of insulin release using a photoswitchable sulfonylurea

Sulfonylureas are widely prescribed for the treatment of type 2 diabetes mellitus (T2DM). Through their actions on ATP-sensitive potassium (K(ATP)) channels, sulfonylureas boost insulin release from the pancreatic beta cell mass to restore glucose homeostasis. A limitation of these compounds is the...

Descripción completa

Detalles Bibliográficos
Autores principales: Broichhagen, Johannes, Schönberger, Matthias, Cork, Simon C., Frank, James A., Marchetti, Piero, Bugliani, Marco, Shapiro, A. M. James, Trapp, Stefan, Rutter, Guy A., Hodson, David J., Trauner, Dirk
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Pub. Group 2014
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4208094/
https://www.ncbi.nlm.nih.gov/pubmed/25311795
http://dx.doi.org/10.1038/ncomms6116

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4208094/
https://www.ncbi.nlm.nih.gov/pubmed/25311795
http://dx.doi.org/10.1038/ncomms6116

Ejemplares similares